Collegium Pharmaceutical, Inc. COLL
Set alert
23.68 USD -0.12 -0.50%
At close · Nov 2
23.68 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
23.27 Day range 24.08
21.43 52-week range 50.79
- YTD
- -48.86%
- 1 year
- -34.22%
- Open
- 23.96
- Prev close
- 23.80
- Mkt cap
- 770.92M
- Vol
- 600.67K
- Avg vol
- 820.34K
- EPS
- 1.27
- P/E
- 18.65
- Div yield
- 0.00%
More statistics
- Low
- 23.27
- High
- 24.08
- Forward P/E
- 4.86
- Beta
- 0.73
- Short ratio
- 0.00
- Inst. own
- 128.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 34.80
- 200-d avg
- 39.23
- 1y target
- 53.60
3M chart
Events in this range
- Aug 6, 2026Earnings: 1.92; estimate 1.72; surprise 11.63%
Signals (14)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| RSI: Oversold | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 53.60
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
5 analysts give a price target
- This month 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.78 | 1.75 – 1.81 | 1.68 | +5.9% | 200.65M | +6.7% | 2 |
| Current quarter | 1.52 | 1.27 – 1.74 | 1.49 | +2.3% | 184.46M | +3.8% | 5 |
| Current quarter | 1.86 | 1.79 – 1.95 | 1.61 | +15.5% | 189.12M | +18.7% | 4 |
| Current quarter | 1.85 | 1.50 – 2.55 | 1.62 | +14.2% | 180.88M | +24.5% | 4 |
| Current quarter | 1.45 | 1.34 – 1.66 | 1.45 | 0.0% | 173.08M | +19.4% | 4 |
| Current quarter | 1.59 | 1.45 – 1.84 | 0.53 | +200.0% | 155.57M | 0.0% | 4 |
| Current quarter | 1.51 | 1.37 – 1.62 | 0.34 | +344.1% | 143.94M | +4.0% | 4 |
| Current quarter | 0.73 | 0.65 – 0.78 | -0.51 | +243.1% | 146.85M | +3.1% | 3 |
| Current quarter | 0.52 | 0.47 – 0.60 | 0.01 | +5100.0% | 138.53M | +9.1% | 3 |
| Current quarter | 0.29 | 0.17 – 0.35 | -0.15 | +293.3% | 138.40M | +12.0% | 4 |
| Current quarter | 0.55 | 0.13 – 1.12 | -0.39 | +241.0% | 142.39M | +70.0% | 5 |
| Current quarter | -0.13 | -0.66 – 0.34 | 0.22 | -159.1% | 124.33M | +46.5% | 4 |
| Current quarter | 1.42 | 1.08 – 1.97 | 0.83 | +71.1% | 121.66M | +46.7% | 7 |
| Current quarter | 0.90 | 0.44 – 1.04 | 0.96 | -6.2% | 78.88M | -3.7% | 6 |
| Current quarter | 0.95 | 0.90 – 1.03 | 0.32 | +196.9% | 84.89M | 0.0% | 6 |
| Current quarter | 0.36 | 0.28 – 0.42 | 0.23 | +56.5% | 84.77M | +13.9% | 4 |
| Current quarter | 0.30 | 0.25 – 0.35 | 0.01 | +2900.0% | 81.87M | +7.0% | 4 |
| Current quarter | 0.22 | 0.08 – 0.34 | -0.18 | +222.2% | 77.43M | +6.2% | 5 |
| Current quarter | 0.20 | 0.03 – 0.29 | -0.14 | +242.9% | 74.40M | -1.7% | 5 |
| Current quarter | 0.37 | 0.08 – 0.64 | -0.29 | +227.6% | 76.68M | +2.9% | 6 |
| Current quarter | -0.15 | -0.26 – -0.01 | -0.50 | +70.0% | 74.32M | +5.9% | 6 |
| Current quarter | -0.18 | -0.25 – -0.11 | -0.40 | +55.0% | 75.67M | +3.6% | 6 |
| Current quarter | -0.24 | -0.40 – -0.12 | -0.57 | +57.9% | 70.82M | +11.1% | 5 |
| Current quarter | -0.34 | -0.44 – -0.28 | -0.45 | +24.4% | 74.79M | +525.9% | 5 |
| Current quarter | -0.42 | -0.67 – -0.31 | -0.72 | +41.7% | 72.20M | +1928.1% | 6 |
| Current quarter | -0.49 | -0.73 – -0.23 | -0.79 | +38.0% | 59.75M | +2650.9% | 5 |
| Current quarter | -0.74 | -0.80 – -0.67 | -1.13 | +34.5% | 5.37M | +1216.2% | 6 |
| Current quarter | -0.81 | -0.85 – -0.76 | -1.05 | +22.9% | 3.64M | 0.0% | 5 |
| Next quarter | 2.10 | 1.93 – 2.32 | 2.25 | -6.7% | 234.75M | +12.1% | 4 |
| Current year | 7.78 | 7.29 – 8.25 | 7.42 | +4.9% | 872.90M | +11.8% | 4 |
| Current year | 7.47 | 7.24 – 7.60 | 6.45 | +15.8% | 781.48M | +23.8% | 5 |
| Current year | 6.18 | 6.07 – 6.27 | 5.47 | +13.0% | 629.18M | +11.0% | 4 |
| Current year | 1.08 | 1.07 – 1.09 | -0.74 | +245.9% | 564.84M | +21.8% | 2 |
| Current year | -0.64 | -1.32 – -0.22 | 2.08 | -130.8% | 459.46M | +65.9% | 4 |
| Current year | 3.70 | 3.59 – 3.77 | 0.76 | +386.8% | 332.48M | +7.2% | 3 |
| Current year | 0.85 | 0.82 – 0.93 | -0.68 | +225.0% | 310.02M | +4.5% | 5 |
| Current year | -0.73 | -0.86 – -0.40 | -1.19 | +38.7% | 295.82M | +5.5% | 5 |
| Current year | -1.82 | -1.96 – -1.70 | -2.47 | +26.3% | 280.62M | +885.5% | 6 |
| Current year | -2.53 | -2.62 – -2.42 | -3.88 | +34.8% | 27.64M | +1515.4% | 7 |
| Next year | 7.51 | 5.66 – 9.28 | 7.78 | -3.5% | 866.02M | -0.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2026 | Needham | Reiterated | Buy | Buy |
| Feb 26, 2026 | Needham | Maintained | Buy | Buy |
| Jan 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 9, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 8, 2026 | Needham | Maintained | Buy | Buy |
| Dec 9, 2025 | Barclays | Initiated | — | Overweight |
| Nov 7, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 7, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 28, 2025 | Needham | Reiterated | Buy | Buy |
| May 9, 2025 | Piper Sandler | Reiterated | Neutral | Neutral |
| Apr 9, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 4, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 10, 2025 | Needham | Upgrade | Hold | Buy |
| Jan 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 11, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| Sep 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 9, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| Aug 9, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 9, 2024 | Needham | Reiterated | — | Hold |
| Jul 30, 2024 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Jul 30, 2024 | Needham | Reiterated | — | Hold |
| Jun 7, 2024 | Jefferies | Upgrade | Hold | Buy |
| May 10, 2024 | Needham | Downgrade | Buy | Hold |
| May 10, 2024 | Piper Sandler | Downgrade | Overweight | Neutral |
| Apr 11, 2024 | Needham | Reiterated | Buy | Buy |
| Feb 26, 2024 | Truist Securities | Maintained | Buy | Buy |
| Feb 23, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 2, 2024 | Needham | Reiterated | Buy | Buy |